A meta-analysis of retention in methadone maintenance by dose and dosing strategy
- PMID: 19152203
- PMCID: PMC3689307
- DOI: 10.1080/00952990802342899
A meta-analysis of retention in methadone maintenance by dose and dosing strategy
Abstract
Objective: To estimate, via meta-analysis, the influence of different methadone dose ranges and dosing strategies on retention rates in methadone maintenance treatment (MMT).
Methods: A systematic literature search identified 18 randomized controlled trials (RCTs) evaluating methadone dose and retention. Retention was defined as the percentage of patients remaining in treatment at a specified time point. After initial univariate analyses of retention by Pearson chi-squares, we used multilevel logistic regression to calculate summary odds ratios (ORs) and 95% confidence intervals for the effects of methadone dose (above or below 60 mg/day), flexible vs. fixed dosing strategy, and duration of follow-up.
Results: The total number of opioid-dependent participants in the 18 studies was 2831, with 1797 in MMT and 1034 receiving alternative mediations or placebo. Each variable significantly predicted retention with the other variables controlled for. Retention was greater with methadone doses > or = 60 than with doses < 60 (OR: 1.74, 95% CI: 1.43-2.11). Similarly, retention was greater with flexible-dose strategies than with fixed-dose strategies (OR: 1.72, 95% CI: 1.41-2.11).
Conclusions: Higher doses of methadone and individualization of doses are each independently associated with better retention in MMT.
Conflict of interest statement
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.
Similar articles
-
The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.Addiction. 2021 Jan;116(1):83-93. doi: 10.1111/add.15115. Epub 2020 Aug 9. Addiction. 2021. PMID: 32428276 Free PMC article.
-
[Characteristics and associated factors of long-term retention for methadone maintenance treatment patients].Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Nov;46(11):995-8. Zhonghua Yu Fang Yi Xue Za Zhi. 2012. PMID: 23363919 Chinese.
-
Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials.Syst Rev. 2021 Aug 6;10(1):216. doi: 10.1186/s13643-021-01764-9. Syst Rev. 2021. PMID: 34362464 Free PMC article. Review.
-
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.Drug Alcohol Depend. 2002 Feb 1;65(3):283-90. doi: 10.1016/s0376-8716(01)00171-5. Drug Alcohol Depend. 2002. PMID: 11841899
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.J Subst Abuse Treat. 2016 Jul;66:37-47. doi: 10.1016/j.jsat.2016.03.003. Epub 2016 Mar 24. J Subst Abuse Treat. 2016. PMID: 27211995 Free PMC article.
-
The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs.Health Serv Res. 2017 Oct;52(5):1881-1907. doi: 10.1111/1475-6773.12558. Epub 2016 Sep 12. Health Serv Res. 2017. PMID: 27618580 Free PMC article.
-
The pharmacological treatment of opioid addiction--a clinical perspective.Eur J Clin Pharmacol. 2010 Jun;66(6):537-45. doi: 10.1007/s00228-010-0793-6. Epub 2010 Feb 19. Eur J Clin Pharmacol. 2010. PMID: 20169438 Review.
-
Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.Harm Reduct J. 2017 Sep 7;14(1):63. doi: 10.1186/s12954-017-0189-3. Harm Reduct J. 2017. PMID: 28882155 Free PMC article.
-
A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States.J Headache Pain. 2022 May 4;23(1):54. doi: 10.1186/s10194-022-01413-z. J Headache Pain. 2022. PMID: 35508970 Free PMC article.
References
-
- Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med. 1966;118(4):304–309. - PubMed
-
- Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs. High-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999;281(11):1000–1005. - PubMed
-
- Dole VP, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969;19:1372–1375. - PubMed
-
- Dole VP, Nyswander ME. A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrochloride. JAMA. 1965;193(8):80–84. - PubMed
-
- Metzger DS, Woody GE, McLellan AT, O’Brien CP, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6(9):1049–1056. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical